MDCG 2022-13 – Designation, re-assessment and notification of conformity assessment bodies and notified bodies
The document aims to provide guidance to the authorities responsible for notified bodies and joint assessment teams when conducting:
i. assessments of conformity assessments bodies that apply for designation as a notified body (NB) in the field of medical devices and/or in vitro diagnostic medical devices, and
ii. re-assessments of NBs.
Read the news announcement published by EC Directorate-General for Health and Food Safety on 10 August 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (24 octobre 2022). MDCG 2022-13 – Designation, re-assessment and notification of conformity assessment bodies and notified bodies. ELSIBI. Consulté le 19 janvier 2026 à l’adresse https://doi.org/10.58079/o632





